ELAB Stock Price | Elevai Labs, Inc. Common Stock P/E, Revenue, EPS, & Forecasts

Elevai Labs, Inc. Common Stock • ELAB

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Elevai Labs, Inc. Common Stock

Ticker

ELAB

Trading on

NASDAQ

ISIN

US28622K1043

Industry

Biotechnology

Sector

Healthcare

CEO

Graydon Bensler C.F.A.

Headquarters

120 Newport Center Drive, Newport Beach, CA, United States, 92660

Employees

Website

https://pmgcholdings.com

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.

Metrics

BasicAdvanced

Market cap

$1.7M

P/E ratio

EPS

-$50.47

Dividend Yield

0.00%

Beta

Forward P/E ratio

EBIDTA

$-3.4M

Ex dividend date

Price & volume

Market cap

$1.7M

Average daily volume

1.4M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

2.34

Price to book

0.26

Earnings

EPS

-$50.47

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-3.4M

Revenues (TTM)

$2.4M

Revenues per share (TTM)

$194.03

Technicals

Beta

52-week High

$980.00

52-week Low

$2.14

50-day moving average

$4.82

200-day moving average

$141.56

Short ratio

0.12

Short %

17.46%

Management effectiveness

ROE (TTM)

76.61%

ROA (TTM)

30.40%

Profit margin

0.00%

Gross profit margin

$1.7M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

4.90%

Share stats

Outstanding Shares

0.7M

Float

0.6M

Insiders %

0.76%

Institutions %

0.60%

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$93.54

Q4 • 23Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0.5M

$-1.5M

284.61%

Q3 • 24

$-1.7M

$4.3M

246.69%

Q4 • 24

431.31%

387.16%

13.33%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$11.2M

$2.7M

23.65%

Q3 • 24

$9M

$2.3M

25.95%

Q4 • 24

19.74%

11.94%

9.72%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-0.4M

$-0.1M

$6.8M

$-0.4M

Q3 • 24

$-2M

$-0.4M

$-0M

$-2.3M

Q4 • 24

424.14%

778.17%

100.00%

432.93%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Elevai Labs, Inc. Common Stock share?

Elevai Labs, Inc. Common Stock shares are currently traded for undefined per share.

How many shares does Elevai Labs, Inc. Common Stock have?

Elevai Labs, Inc. Common Stock currently has 0.7M shares.

Does Elevai Labs, Inc. Common Stock pay dividends?

No, Elevai Labs, Inc. Common Stock doesn't pay dividends.

What is Elevai Labs, Inc. Common Stock 52 week high?

Elevai Labs, Inc. Common Stock 52 week high is $980.00.

What is Elevai Labs, Inc. Common Stock 52 week low?

Elevai Labs, Inc. Common Stock 52 week low is $2.14.

What is the 200-day moving average of Elevai Labs, Inc. Common Stock?

Elevai Labs, Inc. Common Stock 200-day moving average is $141.56.

Who is Elevai Labs, Inc. Common Stock CEO?

The CEO of Elevai Labs, Inc. Common Stock is Graydon Bensler C.F.A..

How many employees Elevai Labs, Inc. Common Stock has?

Elevai Labs, Inc. Common Stock has 2 employees.

What is the market cap of Elevai Labs, Inc. Common Stock?

The market cap of Elevai Labs, Inc. Common Stock is $1.7M.

What is the P/E of Elevai Labs, Inc. Common Stock?

The current P/E of Elevai Labs, Inc. Common Stock is null.

What is the EPS of Elevai Labs, Inc. Common Stock?

The EPS of Elevai Labs, Inc. Common Stock is -$50.47.

What is the PEG Ratio of Elevai Labs, Inc. Common Stock?

The PEG Ratio of Elevai Labs, Inc. Common Stock is null.